Evidence map›Paper›PMID 41852911›Full record

ArticleFrontiers in artificial intelligence2026

Phenotyping cardiogenic shock: an insight from the gulf cardiogenic shock registry.

Ahmed Elmahrouk, Amin Daoulah, Ahmed Jamjoom, Nooraldaem Yousif, Wael Almahmeed, Prashanth Panduranga, Abdulrahman Arabi, Omar Kanbr, Hatem M Aloui, Mohammed Alshehri and 26 more

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Ahmed ElmahroukKing Faisal Specialist Hospital and Research Centre - Jeddah, Jeddah, Saudi Arabia.
Amin DaoulahKing Faisal Specialist Hospital and Research Centre - Jeddah, Jeddah, Saudi Arabia.
Ahmed JamjoomKing Faisal Specialist Hospital and Research Centre - Jeddah, Jeddah, Saudi Arabia.
Nooraldaem YousifMohammed bin Khalifa bin Salman Al Khalifa Specialist Cardiac Centre, Awali, Bahrain.
Wael AlmahmeedCleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Prashanth PandurangaNational Heart Center, Royal Hospital, Muscat, Oman.
Abdulrahman ArabiHamad Medical Corporation, Doha, Qatar.
Omar KanbrFaculty of Medicine, Elrazi University, Khartoum, Sudan.
Hatem M AlouiKing Saud Medical City, Riyadh, Saudi Arabia.
Mohammed AlshehriPrince Khaled Bin Sultan Cardiac Center, Khamis Mushait, Saudi Arabia.
Badr AlzahraniPrince Sultan Cardiac Center, Riyadh, Saudi Arabia.
Shaber SerajTH Chan School of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.
Adnan HussienKing's College Hospital London, Jeddah, Saudi Arabia.
Waleed AlharbiCardiac Sciences Department, King Saud University, Riyadh, Saudi Arabia.
Mohammed A QutubDepartment of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Mokhtar KahinInternational Medical Center, Jeddah, Saudi Arabia.
Abdullah AleneziChest Diseases Hospital, Kuwait City, Kuwait.
Mohamed Ajaz GhaniDepartment of Cardiology, Madinah Cardiac Center, Almadinah, Saudi Arabia.
Taher HassanDepartment of Cardiology, Bugshan General Hospital, Jeddah, Saudi Arabia.
Rajesh RajanAl-Amiri Hospital, Kuwait City, Kuwait.
Said Al MaashaniSalalah Heart Center, Sultan Qaboos Hospital, Salalah, Oman.
Abdulwali AbohasanCentral Hospital Hafr Albatin, Hafr Albatin, Saudi Arabia.
Mohammed BalghithCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences College of Public Health and Health Informatics, Riyadh, Saudi Arabia.
Ziad DahdouhKing Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Abdulrahman M AlqahtaniKing Salman Heart Center, King Fahad Medical City, Riyadh, Saudi Arabia.
Ibrahim A M AbdulhabeebKing Abdulaziz Specialist Hospit, Aljawf, Saudi Arabia.
Mohammed Al JarallahAl-Amiri Hospital, Kuwait City, Kuwait.
Mubarak Abdulhadi AldossariKing Saud Medical City, Riyadh, Saudi Arabia.
Harvey AnthonyThe Royal Hospital National Heart Center, Muscat, Oman.
Mohammed Awad Ashour Awad AshourHamad Medical Corporation, Doha, Qatar.
Tarique Shahzad ChacharMohammed bin Khalifa bin Salman Al Khalifa Specialist Cardiac Centre, Awali, Bahrain.
Hassan KhanCleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Abeer M ShawkyFaculty of Medicine, Al-Azhar University, Cairo, Egypt.
Youssef ElmahroukFaculty of Medicine, Tanta University, Tanta, Egypt.
Amir LotfiDepartment of Cardiovascular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.
Amr ArafatResearch and Innovation Institute, Ministry of Defense Health Services, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiogenic shock (CS) is a life-threatening condition characterized by clinical heterogeneity and high mortality. A "one-size-fits-all" approach to management may be suboptimal. We aimed to identify distinct clinical phenotypes of CS using an unsupervised machine learning approach and to characterize their associated mortality and SCAI stages. Methods: We conducted a retrospective analysis of 1,513 patients with CS from the Gulf registry. An unsupervised machine learning methodology was employed, using agglomerative hierarchical clustering on seven key continuous variables (Age, Ejection Fraction, Mean Arterial Pressure, Lactate, pH, Creatinine, and Alanine Transaminase) to identify patient subgroups. The optimal number of clusters was determined using a combination of quantitative metrics and clinical interpretability. The identified phenotypes were then validated against external outcomes, including in-hospital mortality and SCAI Shock Stage. Results: Four distinct clinical phenotypes were identified. Phenotype 1 ("Compensated Low-Risk," Conclusion: In a large, contemporary registry of CS patients, an unsupervised machine learning approach successfully identified four distinct and prognostically significant phenotypes. These data-driven phenotypes, characterized by unique clinical and biomarker profiles, provide a novel framework for risk stratification that moves beyond traditional classification systems and may facilitate the development of personalized therapeutic strategies for cardiogenic shock.

Indexed as

cardiogenic shockcluster analysismachine learningmulti-organ failurephenotypingprognosis

Identifiers

PMID41852911
PMCPMC12992294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.